This grant funds investigator-initiated clinical trials that aim to reduce cancer burden through advances in early detection, screening, prevention, healthcare delivery, quality of life, and survivorship. Projects must meet NIH clinical trial criteria and align with NCI's cancer prevention and control priorities. Trials focused on cancer diagnosis or oncologic therapy are not supported.
Eligible applicants include a wide range of organizations such as small businesses, governments, higher education institutions, nonprofits, and tribal organizations. Specific eligibility details are provided in the full announcement.
